Cargando…
Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial
BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness among older adults in the developed world. The only treatments currently available, such as ranibizumab injections, are for neovascular AMD, which accounts for only 10 to 15% of people with the condition. Hypoxia ha...
Autores principales: | McKeague, Claire, Margrain, Tom H, Bailey, Clare, Binns, Alison M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227140/ https://www.ncbi.nlm.nih.gov/pubmed/24965385 http://dx.doi.org/10.1186/1745-6215-15-246 |
Ejemplares similares
-
Effect of rehabilitation worker input on visual function outcomes in individuals with low vision: study protocol for a randomised controlled trial
por: Acton, Jennifer H., et al.
Publicado: (2016) -
Detection of Early Age-Related Macular Degeneration Using Novel Functional Parameters of the Focal Cone Electroretinogram
por: Wood, Ashley, et al.
Publicado: (2014) -
Protocol for a family-centered behavioral intervention to reduce early childhood caries: the MySmileBuddy program efficacy trial
por: Lumsden, Christie L., et al.
Publicado: (2021) -
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR
por: Terheyden, Jan H., et al.
Publicado: (2020) -
Study on strategies for alighting and boarding in subway stations
por: Sun, Lishan, et al.
Publicado: (2021)